• Tocilizumab Lowers In-Hospitals Deaths, Vaccine Outlook Mixed, Plans To Launch Human Challenge Study: COVID-19 Updates

    Oct 23 | Clinical Reserch News | Tocilizumab lowers in-hospital deaths, a global survey finds mixed responses to vaccine views and in the US they are driven partially by politics, and Monell Chemical Senses Center finds loss of smell more prevalent than we thought. Plus: the UK plans to develop a COVID-19 (SARS-CoV-2) human challenge study model, Texas launches a state-wide antibody study, and a call to action for the upcoming flu season. More

  • Next-Generation Pharmacovigilance With Natural Language Processing

    Oct 22 | Clinical Research News | Surging use of telemedicine technology since the COVID-19 pandemic hit the U.S. earlier this year has resulted in a massive influx of unstructured patient data to sort through when searching for drug safety signals and compiling adverse event reports required by federal regulators. Natural language processing (NLP) thus has a potentially bigger role to play in automating the pharmacovigilance process, starting with interpreting data in free text fields and doing some of the cumbersome analytical work. More

  • COVID-19 Study-A-Thon Highlights Open Science Potential

    Oct 20 | Clinical Research News | In March, a group of date-sharing researchers assembled to review more than 10,000 COVID-19 publications, draft nine protocols, release 13 study packages, and assemble a distributed data network with 37 partners signed on to execute studies. More

  • Virus Susceptibility Age Independent, Low Risk for Newborns with COVID-19 Positive Mom, Immune Cell Activation Resembles Lupus Flare: COVID-19 Updates

    Oct 16 | Clinical Research News I Group of 80 researchers warns against herd immunity approach, UK case of sudden hearing loss linked to COVID-19, 1 in 7 experience neurological injuries, blood type O may have lowest risk, significant percentage of mothers report increased insomnia and anxiety, 20% of young patients hospitalized require intensive care, NIH launches SeroNet to increase antibody testing capacity, MMR vaccine may offer trained immunity, and international open-access database aims to reduce duplication of research. Plus, over 200 molecules identified that impact severity of virus, UC Davis Health testing REGN-COV2 antibody ‘cocktail’, increase in US death rate unexplained by COVID-19 related deaths and more. More

  • EMD Serono Using Machine Learning To Optimize Enrollment

    Oct 15 | Clinical Research News | Merck’s Sylvia Marecki and Omesan Nair teamed up for a presentation on harnessing machine learning to identify causal drivers of enrollment success in clinical trials at the recent Bio-IT World Conference & Expo Virtual. The Operational Design Center (ODC) at EMD Serono, a Merck KGaA affiliate, uses analytics to address study-related business questions such as the anticipated duration of enrollment and how to speed up the process. More

  • Takeda Case Studies On Wearables In Clinical Trials

    Oct 14 | Clinical Research News | Broader adoption of digital biomarkers in clinical trials is dependent on their regulatory approval, and data quality remains the big hurdle, according to Ariel Dowling, director of digital strategy at Takeda Pharmaceuticals, who led a workshop on wearables at the recent Bio-IT World Conference & Expo Virtual. She presented two specific use cases of digital biomarkers for clinical validation and as a primary endpoint for internal decision-making. More

  • Common Cold May Lessen Severity, ‘Brain Fog’ Really PTSD, Eyeglasses A Fourth Defense Mechanism: COVID-19 Updates

    Oct 09 | Clinical Research News | Previous infection with a non-SARS-CoV-2 coronavirus may lessen severity COVID-19. Long term exposure to urban air pollution may have made COVID-19 more deadly for some. 86% of UK residents who tested positive this spring did not have the specific virus symptoms. And a new look at the interrelationship between COVID-19 and cancer. Plus, survey shows patients have concerns about their health and safety at in-office visits, TestBoston trial looks for previous infection, and Israel opens pediatric COVID-19 ward. More

  • Where Two Technologies Intersect Marks a Clinical Research Turning Point

    Oct 08 | Clinical Research News | On a recent survey, nearly 80% of biopharma and device development execs said they plan to use, or are using, AI to improve R&D performance. At the same time, the COVID-19 pandemic has accelerated the industry’s adoption of Decentralized Clinical Trials (DCTs). As these two burgeoning technologies continue to mature, there is an opportunity for transformation in clinical research where AI and DCTs intersect. More

  • Next Step Forward: PRA Named CRO for Leukemia & Lymphoma Society Global Master Clinical Trial

    Oct 05 | Clinical Research News | Last month, the Leukemia & Lymphoma Society (LLS) and PRA Health Sciences announced their partnership in LLS’s first-of-its-kind global master clinical trial to develop new treatments for children with relapsed acute leukemia. The LLS PedAL (Pediatric Acute Leukemia) master clinical trial will simultaneously test multiple targeted therapies for children who experience a relapse of their acute leukemia. Now PRA has signed on as the contract research organization for the trial. More
View more articles
 
DXX-Industry-spotlight
Agilent
The DIA 2020 Global Annual Meeting is more than a meeting: it's an experience focused on the future of health. Spanning the life sciences spectrum, DIA 2020 will compile more than 250 sessions over 13 unique tracks with nine various learning formats, ensuring each attendee has the best learning opportunities.
DXX-Industry-spotlight
Agilent
Barnett International offers comprehensive role-based training for clinical research professionals worldwide. Learn how you can leverage Barnett’s numerous resources for your teams!
Read More